Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Operating Income
4,208.00
3,742.00
3,340.00
2,889.00
2,587.00
2,055.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
4,208.00
3,742.00
3,340.00
2,889.00
2,587.00
2,055.00
Expenditure (Ex Depriciation)
Stock Adjustments
-39.00
25.00
-83.00
-150.00
-16.00
-56.00
Raw Materials Consumed
1,105.00
1,024.00
915.00
795.00
672.00
440.00
Power & Fuel Cost
66.00
65.00
54.00
43.00
38.00
32.00
Employee Cost
900.00
785.00
645.00
548.00
485.00
430.00
Operating Expenses
168.00
185.00
170.00
119.00
125.00
112.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
417.00
463.00
400.00
374.00
413.00
320.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
85.00
87.00
56.00
50.00
64.00
84.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
3,036.00
2,959.00
2,411.00
1,891.00
1,904.00
1,488.00
Operating Profit (PBDIT) excl Other Income
1,171.00
783.00
929.00
998.00
683.00
566.00
Other Income
84.00
98.00
115.00
25.00
92.00
21.00
Operating Profit (PBDIT)
1,256.00
881.00
1,044.00
1,024.00
775.00
587.00
Interest
7.00
5.00
10.00
8.00
11.00
1.00
Profit before Depriciation and Tax
1,249.00
876.00
1,034.00
1,016.00
763.00
586.00
Depreciation
135.00
130.00
125.00
116.00
95.00
72.00
Profit Before Taxation & Exceptional Items
1,113.00
745.00
909.00
900.00
667.00
514.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
1,113.00
745.00
909.00
900.00
663.00
514.00
Provision for Tax
297.00
157.00
196.00
246.00
196.00
127.00
Profit After Tax
816.00
587.00
712.00
653.00
467.00
386.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
3,141.00
2,717.00
2,155.00
1,617.00
1,269.00
963.00
Profit Available for appropriations
3,957.00
3,305.00
2,868.00
2,271.00
1,737.00
1,350.00
Appropriations
3,957.00
3,305.00
2,868.00
2,271.00
1,737.00
1,350.00
Equity Dividend (%)
2,550.00%
350.00%
475.00%
475.00%
650.00%
450.00%
Earnings Per Share
64.82
45.89
54.97
75.09
53.60
43.97
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 8.84% vs 16.41% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 7.62% vs 60.08% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -32.35% vs 30.02% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 13.58% vs 44.48% in Mar 2024
Compare Profit and Loss Results of Ajanta Pharma
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
4,208.00
8,939.00
-4,731.00
-52.93%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
4,208.00
8,939.00
-4,731.00
-52.93%
Expenditure (Ex Depriciation)
Stock Adjustments
-39.00
-46.00
7.00
15.22%
Raw Materials Consumed
1,105.00
2,824.00
-1,719.00
-60.87%
Power & Fuel Cost
66.00
351.00
-285.00
-81.20%
Employee Cost
900.00
1,983.00
-1,083.00
-54.61%
Operating Expenses
168.00
814.00
-646.00
-79.36%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
417.00
532.00
-115.00
-21.62%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
85.00
304.00
-219.00
-72.04%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
3,036.00
7,210.00
-4,174.00
-57.89%
Operating Profit (PBDIT) excl Other Income
1,171.00
1,729.00
-558.00
-32.27%
Other Income
84.00
92.00
-8.00
-8.70%
Operating Profit (PBDIT)
1,256.00
1,821.00
-565.00
-31.03%
Interest
7.00
87.00
-80.00
-91.95%
Profit before Depriciation and Tax
1,249.00
1,734.00
-485.00
-27.97%
Depreciation
135.00
397.00
-262.00
-65.99%
Profit Before Taxation & Exceptional Items
1,113.00
1,336.00
-223.00
-16.69%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
1,113.00
1,131.00
-18.00
-1.59%
Provision for Tax
297.00
343.00
-46.00
-13.41%
Profit After Tax
816.00
787.00
29.00
3.68%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
3,141.00
4,899.00
-1,758.00
-35.88%
Profit Available for appropriations
3,957.00
5,637.00
-1,680.00
-29.80%
Appropriations
3,957.00
5,637.00
-1,680.00
-29.80%
Equity Dividend (%)
2550%
400%
2,150.00
Earnings Per Share
64.82
29.08
35.74
122.90%
Profit And Loss - Net Sales
Net Sales 4,322.04 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 8.84% vs 16.41% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,204.72 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 7.62% vs 60.08% in Mar 2024
Profit And Loss - Interest
Interest 4.60 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -32.35% vs 30.02% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 916.89 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 13.58% vs 44.48% in Mar 2024






